FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anton Stalenhoef

Research Profile

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Mohammad Hassan Murad; Frank Sacks; Anton F H Stalenhoef
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
Martijn C G J Brouwers; Jacqueline de Graaf; Coen D A Stehouwer; Marleen M J van Greevenbroek; Anton F H Stalenhoef
The genetics of familial combined hyperlipidaemia.
Tim B Koenen; Mihai G Netea; Jillis A Pol; Anton F H Stalenhoef; Rinke Stienstra; Cees J Tack; J A van der Vliet; Jeroen F van Velzen; Lambertus J H Van Tits; Anneke Hijmans; Leo A B Joosten; Jacqueline de Graaf
The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anton Stalenhoef (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Mohammad Hassan Murad; Frank Sacks; Anton F H Stalenhoef
Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2012;97(9):2969-89.
2012: Martijn C G J Brouwers; Jacqueline de Graaf; Coen D A Stehouwer; Marleen M J van Greevenbroek; Anton F H Stalenhoef
The genetics of familial combined hyperlipidaemia.
Nature reviews. Endocrinology 2012;8(6):352-62.
2011: Tim B Koenen; Mihai G Netea; Jillis A Pol; Anton F H Stalenhoef; Rinke Stienstra; Cees J Tack; J A van der Vliet; Jeroen F van Velzen; Lambertus J H Van Tits; Anneke Hijmans; Leo A B Joosten; Jacqueline de Graaf
The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue.
Endocrinology 2011;152(10):3769-78.
2011: Suzanne Holewijn; Allan D Sniderman; Martin den Heijer; Dorine W Swinkels; Anton F H Stalenhoef; Jacqueline de Graaf
Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study.
European journal of clinical investigation 2011;41(4):423-33.
2011: Tim B Koenen; Rinke Stienstra; Lambertus J H Van Tits; Jacqueline de Graaf; Anton F H Stalenhoef; Leo A B Joosten; Cees J Tack; Mihai G Netea
Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue.
Diabetes 2011;60(2):517-24.
2010: Martijn C G J Brouwers; Jacqueline de Graaf; Marleen M J van Greevenbroek; Nicolaas Schaper; Coen D A Stehouwer; Anton F H Stalenhoef
Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Current opinion in lipidology 2010;21(6):530-8.
2010: Roeland Huijgen; Evertine J Abbink; Eric Bruckert; Anton F H Stalenhoef; BP Imholz; Paul N Durrington; Mieke D Trip; Mats Eriksson; Frank L J Visseren; Juergen R Schaefer; John J P Kastelein
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Clinical therapeutics 2010;32(4):615-25.
2010: Thomas M Van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H Van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(1):113-20.
2009: Tim B Koenen; Cees J Tack; Jeanne Margot Kroese; Ad R Hermus; Fred C G J Sweep; Jeroen A W M van der Laak; Anton F H Stalenhoef; Jacqueline de Graaf; Lambertus J H Van Tits; Rinke Stienstra
Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
The Journal of clinical endocrinology and metabolism 2009;94(11):4453-7.
2009: Suzanne Holewijn; Martin den Heijer; Dorine W Swinkels; Anton F H Stalenhoef; Jacqueline de Graaf
The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis.
The Journal of clinical endocrinology and metabolism 2009;94(8):2893-9.
2009: Arjen Hoogendam; Pieter F De Vries Robbé; Anton F H Stalenhoef; A John P M Overbeke
Evaluation of PubMed filters used for evidence-based searching: validation using relative recall.
Journal of the Medical Library Association : JMLA 2009;97(3):186-93.
2009: Calin Popa; Lambertus J H Van Tits; Pilar Barrera; H L M Lemmers; F H J van den Hoogen; P L C M van Riel; T R D J Radstake; Mihai G Netea; M Roest; Anton F H Stalenhoef
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
Annals of the rheumatic diseases 2009;68(6):868-72.
2009: Peter Henneman; Femke van der Sman-de Beer; Payman Hanifi Moghaddam; Petra Huijts; Anton F H Stalenhoef; John J P Kastelein; C.M. Duijn; Louis M Havekes; Rune R Frants; Ko Willems van Dijk; August Smelt
The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
European journal of human genetics : EJHG 2009;17(5):620-8.
2009: Calin Popa; Mihai G Netea; Jacqueline de Graaf; F H J van den Hoogen; Timothy R D J Radstake; Helga Toenhake-Dijkstra; Piet L C M van Riel; Jos W M van der Meer; Anton F H Stalenhoef; Pilar Barrera
Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.
The Journal of rheumatology 2009;36(4):724-30.
2009: Anton F H Stalenhoef
The benefit of statins in non-cardiac vascular surgery patients.
Journal of vascular surgery 2009;49(1):260-5.
2009: Mihai G Netea; Leo A B Joosten; Monique Keuter; Frank Wagener; Anton F H Stalenhoef; Jos W M van der Meer; Bart Jan Kullberg
Circulating lipoproteins are a crucial component of host defense against invasive Salmonella typhimurium infection.
PloS one 2009;4(1):e4237.
2009: E M G Jacobs; Jan C M Hendriks; C Th B M van Deursen; Herman G Kreeftenberg; Richard A de Vries; Joannes Marx; Anton F H Stalenhoef; André L M Verbeek; Dorine W Swinkels
Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
Journal of hepatology 2009;50(1):174-83.
2008: Tim B Koenen; Lambertus J H Van Tits; Suzanne Holewijn; H L M Lemmers; Martin den Heijer; Anton F H Stalenhoef; Jacqueline de Graaf
Adiponectin multimer distribution in patients with familial combined hyperlipidemia.
Biochemical and biophysical research communications 2008;376(1):164-8.
2008: Anton F H Stalenhoef; Gerald F Watts
Chylomicrons in disease: a renaissance in lipidology International Symposium of Chylomicrons in Disease (ISCD), Lake Louise, Alberta, Canada, March 6th-8th, 2008.
Atherosclerosis. Supplements 2008;9(2):1-2.
2008: Thomas M Van Himbergen; Yvonne van der Schouw; Hieronymus A M Voorbij; Lambertus J H Van Tits; Anton F H Stalenhoef; Petra Peeters; Mark Roest
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
Atherosclerosis 2008;199(2):408-14.
2008: Thomas M Van Himbergen; Lambertus J H Van Tits; Ewoud ter Avest; Mark Roest; Hieronymus A M Voorbij; Jacqueline de Graaf; Anton F H Stalenhoef
Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
Atherosclerosis 2008;199(1):87-94.
2008: John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico Veltri; Adrian David Marais; Eric de Groot
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
The New England journal of medicine 2008;358(14):1431-43.
2008: Martijn C G J Brouwers; Jacqueline de Graaf; Marleen M J van Greevenbroek; Anna M Georgieva; Carla J H van der Kallen; Ewoud ter Avest; Coen D A Stehouwer; Anton F H Stalenhoef; Tjerk W A de Bruin
Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
Clinical science (London, England : 1979) 2008;114(5):393-401.
2008: Sabine H A Diepeveen; Jack F M Wetzels; Henk J G Bilo; Lambertus J H Van Tits; Anton F H Stalenhoef
Cholesterol in end-stage renal disease: the good, the bad or the ugly?
The Netherlands journal of medicine 2008;66(2):53-61.
2008: Anton F H Stalenhoef
[Cardiovascular prevention in the over-80 age group is beneficial].
Nederlands tijdschrift voor geneeskunde 2008;152(1):26.
2008: Arjen Hoogendam; Anton F H Stalenhoef; Pieter F de Vries Robbé; A John P M Overbeke
Analysis of queries sent to PubMed at the point of care: observation of search behaviour in a medical teaching hospital.
BMC medical informatics and decision making 2008;8():42.
2007: Anton F H Stalenhoef; Janneke J C van Lith-Verhoeven
Blurred vision.
The Netherlands journal of medicine 2007;65(11):461-2.
2007: E M G Jacobs; Jan C M Hendriks; Joannes Marx; C Th B M van Deursen; H G Kreeftenberg; Richard A de Vries; Anton F H Stalenhoef; André L M Verbeek; Dorine W Swinkels
Morbidity and mortality in first-degree relatives of C282Y homozygous probands with clinically detected haemochromatosis compared with the general population: the HEmochromatosis FAmily Study (HEFAS).
The Netherlands journal of medicine 2007;65(11):425-33.
2007: E M G Jacobs; André L M Verbeek; H G Kreeftenberg; C Th B M van Deursen; Joannes Marx; Anton F H Stalenhoef; Dorine W Swinkels; Richard A de Vries
Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis.
The Netherlands journal of medicine 2007;65(11):419-24.
2007: Calin Popa; F H J van den Hoogen; Timothy Radstake; Mihai G Netea; Agnes E Eijsbouts; Martin den Heijer; Jos W M van der Meer; P L C M van Riel; Anton F H Stalenhoef; Pilar Barrera
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(11):1503-7.
2007: Bart Ferwerda; Matthew B B McCall; Santos Alonso; Evangelos J Giamarellos-Bourboulis; Maria Mouktaroudi; Neskuts Izagirre; Din Syafruddin; Gibson S Kibiki; Tudor Cristea; Anneke Hijmans; Lutz Hamann; Shoshana Israel; Gehad Elghazali; Marita Troye-Blomberg; Oliver Kumpf; Boubacar Maiga; Amagana Dolo; Ogobara K Doumbo; Cornelus C Hermsen; Anton F H Stalenhoef; Reinout van Crevel; Han G Brunner; Djin-Ye Oh; Ralf R Schumann; Concepcion de la Rúa; Robert W Sauerwein; Bart Jan Kullberg; Andre J A M van der Ven; Jos W M van der Meer; Mihai G Netea
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(42):16645-50.
2007: Lambertus J H Van Tits; E M G Jacobs; Dorine W Swinkels; H L M Lemmers; Gerly M van der Vleuten; Jacqueline de Graaf; Anton F H Stalenhoef
Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation.
Atherosclerosis 2007;194(1):272-8.
2007: M M Ros; S S Sterk; Hans Verhagen; Anton F H Stalenhoef; Nynke de Jong
Phytosterol consumption and the anabolic steroid boldenone in humans: a hypothesis piloted.
Food additives and contaminants 2007;24(7):679-84.
2007: Anton F H Stalenhoef
[Statins available from chemist shops will not positively affect health].
Nederlands tijdschrift voor geneeskunde 2007;151(25):1405.
2007: Marianne J Hommels; Abraham A Kroon; M G Netea; Peter W de Leeuw; Cathrien A Bruggeman; Tim Leiner; Derk Koster; Anton F H Stalenhoef; Andre J A M van der Ven
The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis.
The Netherlands journal of medicine 2007;65(6):203-7.
2007: J P H Bergmans; Erwin H J M Kemna; Mirian C H Janssen; E M G Jacobs; Anton F H Stalenhoef; Joannes Marx; Dorine W Swinkels
[Hereditary haemochromatosis: novel genes, novel diseases and hepcidin].
Nederlands tijdschrift voor geneeskunde 2007;151(20):1121-7.
2007: Lambertus J H Van Tits; Waander L van Heerde; Gerly M van der Vleuten; Jacqueline de Graaf; Diederick Grobbee; Lucy P L van de Vijver; Anton F H Stalenhoef; Hans M G Princen
Plasma annexin A5 level relates inversely to the severity of coronary stenosis.
Biochemical and biophysical research communications 2007;356(3):674-80.
2007: Ewoud ter Avest; Suzanne Holewijn; Lambertus J H Van Tits; H M de Wit; Anton F H Stalenhoef; Jacqueline de Graaf
Endothelial function in familial combined hyperlipidaemia.
European journal of clinical investigation 2007;37(5):381-9.
2007: Ewoud ter Avest; Anton F H Stalenhoef; Jacqueline de Graaf
What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?
Clinical science (London, England : 1979) 2007;112(10):507-16.
2007: Antoine W T van Lieshout; Calin Popa; Friederike Meyer-Wentrup; H L M Lemmers; Anton F H Stalenhoef; Gosse J Adema; P L C M van Riel; Lambertus J H Van Tits; Timothy Radstake
Circulating CXCL16 is not related to circulating oxLDL in patients with rheumatoid arthritis.
Biochemical and biophysical research communications 2007;355(2):392-7.
2007: Jacqueline de Graaf; Gerly M van der Vleuten; Ewoud ter Avest; Geesje M Dallinga-Thie; Anton F H Stalenhoef
High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.
The Journal of clinical endocrinology and metabolism 2007;92(4):1269-75.
2007: Calin Popa; Mihai G Netea; P L C M van Riel; Jos W M van der Meer; Anton F H Stalenhoef
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.
Journal of lipid research 2007;48(4):751-62.
2007: Ewoud ter Avest; Suzanne Holewijn; S J H Bredie; Lambertus J H Van Tits; Anton F H Stalenhoef; Jacqueline de Graaf
Pulse wave velocity in familial combined hyperlipidemia.
American journal of hypertension 2007;20(3):263-9.
2007: Ewoud ter Avest; Suzanne Holewijn; S J H Bredie; Anton F H Stalenhoef; Jacqueline de Graaf
Remnant particles are the major determinant of an increased intima media thickness in patients with familial combined hyperlipidemia (FCH).
Atherosclerosis 2007;191(1):220-6.
2007: Gerly M van der Vleuten; Aaron Isaacs; Wu-Wei Zeng; Ewoud ter Avest; Philippa J Talmud; Geesje M Dallinga-Thie; C.M. Duijn; Anton F H Stalenhoef; Jacqueline de Graaf
Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
Biochimica et biophysica acta 2007;1772(1):81-8.
2007: Gerly M van der Vleuten; Aaron Isaacs; Anneke Hijmans; C.M. Duijn; Anton F H Stalenhoef; Jacqueline de Graaf
The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.
Journal of lipid research 2007;48(1):193-200.
2007: Ewoud ter Avest; Allan D Sniderman; S J H Bredie; Albert Wiegman; Anton F H Stalenhoef; Jacqueline de Graaf
Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
Clinical science (London, England : 1979) 2007;112(2):131-9.
2006: Anton F H Stalenhoef
[Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
Nederlands tijdschrift voor geneeskunde 2006;150(39):2127-30.
2006: Emily S van Aalst-Cohen; Angelique C M Jansen; Michael W T Tanck; Joep C Defesche; Mieke D Trip; Peter J Lansberg; Anton F H Stalenhoef; John J P Kastelein
Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.
European heart journal 2006;27(18):2240-6.
2006: Joost P H Drenth; P Smits; T Thien; Anton F H Stalenhoef
The case for case reports in the Netherlands Journal of Medicine.
The Netherlands journal of medicine 2006;64(7):262-4.
2006: Lambertus J H Van Tits; E M G Jacobs; Dorine W Swinkels; H L M Lemmers; Gerly M van der Vleuten; Jacqueline de Graaf; Anton F H Stalenhoef
Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis.
Biochemical and biophysical research communications 2006;345(1):371-6.
2006: Mihai G Netea; Leo A B Joosten; Eli Lewis; Dalan R Jensen; Peter J Voshol; Bart Jan Kullberg; Cees J Tack; Han van Krieken; Soo-Hyun Kim; Anton F H Stalenhoef; Fons A J van de Loo; Ineke Verschueren; Leslie Pulawa; Shizuo Akira; Robert H Eckel; Charles A Dinarello; Wim B van den Berg; Jos W M van der Meer
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
Nature medicine 2006;12(6):650-6.
2006: Sita H H M Vermeulen; Gerly M van der Vleuten; Jacqueline de Graaf; Ad R M M Hermus; Henk J Blom; Anton F H Stalenhoef; Martin den Heijer
A genome-wide linkage scan for homocysteine levels suggests three regions of interest.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1303-7.
2006: Gerly M van der Vleuten; Leo A J Kluijtmans; Anneke Hijmans; Henk J Blom; Anton F H Stalenhoef; Jacqueline de Graaf
The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.
International journal of obesity (2005) 2006;30(6):892-8.
2006: Gerly M van der Vleuten; Anneke Hijmans; Sandra Heil; Henk J Blom; Anton F H Stalenhoef; Jacqueline de Graaf
Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?
American journal of medical genetics. Part A 2006;140(9):1010-2.
2006: Lambertus J H Van Tits; Thomas M Van Himbergen; H L M Lemmers; Jacqueline de Graaf; Anton F H Stalenhoef
Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.
Atherosclerosis 2006;185(2):307-12.
2006: Thomas M Van Himbergen; Lambertus J H Van Tits; Mark Roest; Anton F H Stalenhoef
The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.
The Netherlands journal of medicine 2006;64(2):34-8.
2006: Natasja De Bont; Mihai G Netea; Chantal Rovers; Tineke J Smilde; Anneke Hijmans; Pierre N M Demacker; Jos W M van der Meer; Anton F H Stalenhoef
LPS-induced release of IL-1 beta, IL-1Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2006;26(2):101-7.
2006: Hélène W P van den Nieuwenhoff; Ilse Mesters; Joyce J T M Nellissen; Anton F H Stalenhoef; Nanne K de Vries
The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol.
Journal of genetic counseling 2006;15(1):29-40.
2006: E P Walma; Frank L J Visseren; J Wouter Jukema; J J P Kastelein; Arno Hoes; Anton F H Stalenhoef
[The practice guideline 'Diagnosis and treatment of familial hypercholesterolaemia' of the Dutch Health Care Insurance Board].
Nederlands tijdschrift voor geneeskunde 2006;150(1):18-23.
2006: Evertine J Abbink; Jacqueline de Graaf; Jacco H de Haan; Arend Heerschap; Anton F H Stalenhoef; Cees J Tack
Effects of pioglitazone in familial combined hyperlipidaemia.
Journal of internal medicine 2006;259(1):107-16.
2005: Joost P H Drenth; P Smits; T Thien; Anton F H Stalenhoef
The Netherlands Journal of Medicine's hit list: best cited articles in 2003.
The Netherlands journal of medicine 2005;63(11):418-20.
2005: Gerly M van der Vleuten; Mario J Veerkamp; Lambertus J H Van Tits; Helga Toenhake; Martin den Heijer; Anton F H Stalenhoef; Jacqueline de Graaf
Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD.
Atherosclerosis 2005;183(2):355-60.
2005: Anton F H Stalenhoef; Christie M Ballantyne; Cinzia Sarti; Jan Murin; Serena Tonstad; Helen Rose; Wim Wilpshaar
A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.
European heart journal 2005;26(24):2664-72.
2005: T M Himbergen; Lambertus J H Van Tits; Hieronymus A M Voorbij; Jacqueline de Graaf; Anton F H Stalenhoef; Mark Roest
The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.
Journal of internal medicine 2005;258(5):442-9.
2005: Sabine H A Diepeveen; Gertie H W E Verhoeven; Job van der Palen; Bert L D Dikkeschei; Berry L J van Tits; Geert Kolsters; Joop J G Offerman; Henk J G Bilo; Anton F H Stalenhoef
The effect of the initiation of renal replacement therapy on lipid profile and oxidative stress during the first 6 months of treatment.
Clinica chimica acta; international journal of clinical chemistry 2005;361(1-2):112-8.
2005: Gerly M van der Vleuten; Lambertus J H Van Tits; Martin den Heijer; H L M Lemmers; Anton F H Stalenhoef; Jacqueline de Graaf
Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile.
Journal of lipid research 2005;46(11):2398-404.
2005: Calin Popa; Pilar Barrea; Mihai G Netea; Anton F H Stalenhoef; Jos W M van der Meer
Anti-TNF therapy and plasma HDL cholesterol concentration.
Atherosclerosis 2005;182(2):375; author reply 377.
2005: Ewoud ter Avest; Evertine J Abbink; Suzanne Holewijn; Jacqueline de Graaf; Cees J Tack; Anton F H Stalenhoef
Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
Current medical research and opinion 2005;21(9):1469-76.
2005: Ewoud ter Avest; Evertine J Abbink; Jacqueline de Graaf; Cees J Tack; Anton F H Stalenhoef
Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.
European journal of clinical investigation 2005;35(9):558-64.
2005: G Kees Hovingh; Barbara A Hutten; Adriaan G Holleboom; Wilma Petersen; Patrick Rol; Anton F H Stalenhoef; Aeilko H Zwinderman; Eric de Groot; John J P Kastelein; Jan Albert Kuivenhoven
Compromised LCAT function is associated with increased atherosclerosis.
Circulation 2005;112(6):879-84.
2005: Thomas M Van Himbergen; Lambertus J H Van Tits; Magda P C Hectors; Jacqueline de Graaf; Mark Roest; Anton F H Stalenhoef
Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.
Biochemical and biophysical research communications 2005;333(3):787-93.
2005: Lambertus J H Van Tits; E Arioglu-Oral; C G J Sweep; Paul Smits; Anton F H Stalenhoef; Cees J Tack
Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity.
The Netherlands journal of medicine 2005;63(7):250-5.
2005: Lambertus J H Van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial".
Circulation 2005;111(18):e284-5; author reply e284-5.
2005: Sabine H A Diepeveen; G W H E Verhoeven; Job van der Palen; Lambert D Dikkeschei; Lambertus J H Van Tits; Geert Kolsters; Joop J G Offerman; Henk J G Bilo; Anton F H Stalenhoef
Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial.
Journal of internal medicine 2005;257(5):438-45.
2005: Anton F H Stalenhoef
Management of mixed hyperlipidaemia.
European heart journal 2005;26(9):856-7.
2005: Mario J Veerkamp; Jacqueline de Graaf; Anton F H Stalenhoef
Role of insulin resistance in familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(5):1026-31.
2005: Ewoud ter Avest; Suzanne Holewijn; Anton F H Stalenhoef; Jacqueline de Graaf
Variation in non-invasive measurements of vascular function in healthy volunteers during daytime.
Clinical science (London, England : 1979) 2005;108(5):425-31.
2005: Lambertus J H Van Tits; Jacqueline de Graaf; Helga Toenhake; Waander L van Heerde; Anton F H Stalenhoef
C-reactive protein and annexin A5 bind to distinct sites of negatively charged phospholipids present in oxidized low-density lipoprotein.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(4):717-22.
2005: Thomas M Van Himbergen; Mark Roest; Jacqueline de Graaf; E H J M Jansen; Hiroaki Hattori; John J P Kastelein; Hieronymus A M Voorbij; Anton F H Stalenhoef; Lambertus J H Van Tits
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.
Journal of lipid research 2005;46(3):445-51.
2005: C Popa; M G Netea; Timothy Radstake; J W M Van der Meer; Anton F H Stalenhoef; P L C M van Riel; P Barerra
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(2):303-5.
2005: Sanne van Wissen; Tineke J Smilde; Mieke D Trip; Anton F H Stalenhoef; John J P Kastelein
Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia.
The American journal of cardiology 2005;95(2):264-6.
2004: C Soetevent; P L Klemm; Anton F H Stalenhoef; S J H Bredie
Vascular graft infection in aortoiliac and aortofemoral bypass surgery: clinical presentation, diagnostic strategies and results of surgical treatment.
The Netherlands journal of medicine 2004;62(11):446-52.
2004: Greetje J de Grooth; Anke H E M Klerkx; Erik S G Stroes; Anton F H Stalenhoef; John J P Kastelein; Jan Albert Kuivenhoven
A review of CETP and its relation to atherosclerosis.
Journal of lipid research 2004;45(11):1967-74.
2004: Gerly M van der Vleuten; Anneke Hijmans; Leo A J Kluijtmans; Henk J Blom; Anton F H Stalenhoef; Jacqueline de Graaf
Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.
American journal of medical genetics. Part A 2004;130A(1):73-5.
2004: Jacqueline de Graaf; Gerly M van der Vleuten; Anton F H Stalenhoef
Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
Seminars in vascular medicine 2004;4(3):229-40.
2004: Alieke G Vonk; Natasja De Bont; Mihai G Netea; Pierre N M Demacker; Jos W M van der Meer; Anton F H Stalenhoef; Bart Jan Kullberg
Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(4):341-8.
2004: Mihai G Netea; Bart Jan Kullberg; Liesbeth E H Jacobs; Trees J G Verver-Jansen; Johanna van der Ven-Jongekrijg; Jochem M D Galama; Anton F H Stalenhoef; Charles A Dinarello; Jos W M van der Meer
Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(2):1477-82.
2004: Wim G Goettsch; Donald D Yin; Evo Alemao; Olaf Klungel; Anton F H Stalenhoef; Ron Herings
Statins are less effective in common daily practice among patients with hypercholesterolemia: the REALITY-PHARMO study.
Current medical research and opinion 2004;20(7):1025-33.
2004: Mario J Veerkamp; Jacqueline de Graaf; Jan C M Hendriks; Pierre N M Demacker; Anton F H Stalenhoef
Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Circulation 2004;109(24):2980-5.
2004: Thomas M Van Himbergen; Mark Roest; Frouwkje de Waart; Jacqueline de Graaf; Hieronymus A M Voorbij; Lambertus J H Van Tits; Anton F H Stalenhoef
Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.
Free radical research 2004;38(6):553-60.
2004: Anna Simon; Elizabeth Drewe; Jos W M van der Meer; Richard J Powell; Richard I Kelley; Anton F H Stalenhoef; Joost P H Drenth
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
Clinical pharmacology and therapeutics 2004;75(5):476-83.
2004: Lambertus J H Van Tits; Tineke J Smilde; Sanne van Wissen; Jacqueline de Graaf; John J P Kastelein; Anton F H Stalenhoef
Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2004;52(3):177-84.
2004: Greetje J de Grooth; Tineke J Smilde; Sanne van Wissen; Anke H E M Klerkx; Aeilko H Zwinderman; Jean-Charles Fruchart; John J P Kastelein; Anton F H Stalenhoef; Jan Albert Kuivenhoven
The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.
Atherosclerosis 2004;173(2):261-7.
2004: Tom Sprong; Mihai G Netea; Peter van der Ley; Trees J G Verver-Jansen; Liesbeth E H Jacobs; Anton F H Stalenhoef; Jos W M van der Meer; Marcel van Deuren
Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria.
Journal of lipid research 2004;45(4):742-9.
2004: Jessica Rodenburg; Albert Wiegman; Maud N Vissers; J J P Kastelein; Anton F H Stalenhoef
A boy with autosomal recessive hypercholesterolaemia.
The Netherlands journal of medicine 2004;62(3):89-93.
2004: Mihai G Netea; Anneke Hijmans; Sanne van Wissen; Tineke J Smilde; Mieke D Trip; Bart Jan Kullberg; Theo M de Boo; J W M Van Der Meer; J J P Kastelein; Anton F H Stalenhoef; A F H Stalenhorf
Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia.
European journal of clinical investigation 2004;34(2):94-9.
2004: Sabine H A Diepeveen; Gertie H W E Verhoeven; Job van der Palen; Bert L D Dikkeschei; Lambertus J H Van Tits; Geert Kolsters; Joop J G Offerman; Henk J G Bilo; Anton F H Stalenhoef
Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
Nephron. Clinical practice 2004;98(1):c3-7.
2003: Sanne van Wissen; Tineke J Smilde; Eric de Groot; Barbara A Hutten; John J P Kastelein; Anton F H Stalenhoef
The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2003;10(6):451-5.
2003: Sanne van Wissen; Tineke J Smilde; Mieke D Trip; Theo M de Boo; J J P Kastelein; Anton F H Stalenhoef
Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
Heart (British Cardiac Society) 2003;89(8):893-6.
2003: Anton F H Stalenhoef
Images in clinical medicine. Phytosterolemia and xanthomatosis.
The New England journal of medicine 2003;349(1):51.
2003: E M G Jacobs; Richard A de Vries; Lammy D Elving; Anton F H Stalenhoef; Dorine W Swinkels
[Diagnosis of 5 patients with possible primary hemochromatosis].
Nederlands tijdschrift voor geneeskunde 2003;147(14):666-70.
2003: Henry N Ginsberg; Anton F H Stalenhoef
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
Journal of cardiovascular risk 2003;10(2):121-8.
2003: Judith M van den Akker; S J H Bredie; Sabine H A Diepenveen; Lambertus J H Van Tits; Anton F H Stalenhoef; Rob van Leusen
Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL.
Journal of nephrology 2003;16(2):238-44.
2003: Mieke D Trip; Sanne van Wissen; Tineke J Smilde; Barbara A Hutten; Anton F H Stalenhoef; John J P Kastelein
Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia.
The American journal of cardiology 2003;91(5):604-6.
2003: Lambertus J H Van Tits; Frouwkje de Waart; Heidi L M Hak-Lemmers; Jacqueline de Graaf; Pierre N M Demacker; Anton F H Stalenhoef
Neutrophil superoxide-anion generating capacity in chronic smoking: effect of long-term alpha-tocopherol therapy.
Journal of biosciences 2003;28(1):23-7.
2003: Anne G Semb; Sanne van Wissen; Thor Ueland; Tineke J Smilde; Torgun Waehre; Mieke D Tripp; Stig S Frøland; John J P Kastelein; Lars Gullestad; Terje R Pedersen; Pål Aukrust; Anton F H Stalenhoef
Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy.
Journal of the American College of Cardiology 2003;41(2):275-9.
2003: Lambertus J H Van Tits; Jacqueline de Graaf; Heidi L M Hak-Lemmers; S J H Bredie; Pierre N M Demacker; Paul Holvoet; Anton F H Stalenhoef
Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis.
Laboratory investigation; a journal of technical methods and pathology 2003;83(1):13-21.
2003: Mario J Veerkamp; Jacqueline de Graaf; Martin den Heijer; Henk J Blom; Anton F H Stalenhoef
Plasma homocysteine in subjects with familial combined hyperlipidemia.
Atherosclerosis 2003;166(1):111-7.
2002: J W M van der Meer; Anton F H Stalenhoef; P Smits; Th Thien
Abstract!
The Netherlands journal of medicine 2002;60(11):418.
2002: Sanne van Wissen; Mieke D Trip; Tineke J Smilde; Jacqueline de Graaf; Anton F H Stalenhoef; John J P Kastelein
Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy.
Atherosclerosis 2002;165(2):361-6.
2002: S J H Bredie; Hub Wollersheim; Jacques W M Lenders; Anton F H Stalenhoef
[The added value of a structured evaluation of patients with vascular disease].
Nederlands tijdschrift voor geneeskunde 2002;146(48):2277-81.
2002: Jacqueline de Graaf; Pernette R W de Sauvage Nolting; Marjel Van Dam; Elizabeth M Belsey; John J P Kastelein; P Haydn Pritchard; Anton F H Stalenhoef
Consumption of tall oil-derived phytosterols in a chocolate matrix significantly decreases plasma total and low-density lipoprotein-cholesterol levels.
The British journal of nutrition 2002;88(5):479-88.
2002: Alan D Attie; Ronald M Krauss; Mark P Gray-Keller; Alison Brownlie; Makoto Miyazaki; John J Kastelein; Aldons J Lusis; Anton F H Stalenhoef; Jonathan P Stoehr; Michael R Hayden; James M Ntambi
Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.
Journal of lipid research 2002;43(11):1899-907.
2002: Anton F H Stalenhoef; P M J Stuyt
[Broader indication for treatment with statins; the 'heart protection study'].
Nederlands tijdschrift voor geneeskunde 2002;146(41):1921-3.
2002: Anton F H Stalenhoef
Interaction between genes and environment in inherited lipid disorders determines clinical presentation.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(4):271-2.
2002: Mihai G Netea; Bart Jan Kullberg; Pierre N M Demacker; Liesbeth E H Jacobs; Trees J G Verver-Jansen; Anneke Hijmans; Lambertus H J van Tits; Joost G J Hoenderop; Peter H G M Willems; Jos W M van der Meer; Anton F H Stalenhoef
Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells.
Journal of lipid research 2002;43(7):1065-71.
2002: Greetje J de Grooth; Jan Albert Kuivenhoven; Anton F H Stalenhoef; Jacqueline de Graaf; Aeilko H Zwinderman; Jan L Posma; Arie Van Tol; John J P Kastelein
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study.
Circulation 2002;105(18):2159-65.
2002: Mihai G Netea; Bart Jan Kullberg; Jochem M D Galama; Anton F H Stalenhoef; Charles A Dinarello; Jos W M van der Meer
Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways.
European journal of immunology 2002;32(4):1188-95.
2002: Femke de Beer; Anton F H Stalenhoef; Nicoline Hoogerbrugge; John J P Kastelein; Jan A Gevers Leuven; C.M. Duijn; Louis M Havekes; August Smelt
Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(2):294-9.
2002: Mario J Veerkamp; Jacqueline de Graaf; S J H Bredie; Jan C M Hendriks; Pierre N M Demacker; Anton F H Stalenhoef
Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(2):274-82.
2002: Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.
Journal of the Royal Society of Medicine 2002;95 Suppl 42():46-53.
2001: Tineke J Smilde; Sanne van Wissen; Hub Wollersheim; John J P Kastelein; Anton F H Stalenhoef
Genetic and metabolic factors predicting risk of cardiovascular disease in familial hypercholesterolemia.
The Netherlands journal of medicine 2001;59(4):184-95.
2001: Frouwkje de Waart; Frans J Kok; Tineke J Smilde; Anneke Hijmans; Hub Wollersheim; Anton F H Stalenhoef
Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers.
Atherosclerosis 2001;158(1):227-31.
2001: Lambertus J H Van Tits; Frouwkje de Waart; Heidi L M Hak-Lemmers; P van Heijst; Jacqueline de Graaf; Pierre N M Demacker; Anton F H Stalenhoef
Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers.
Free radical biology & medicine 2001;30(10):1122-9.
2001: S J H Bredie; Frank H Bosch; Pierre N M Demacker; Anton F H Stalenhoef; Rob van Leusen
Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2001;21(3):275-81.
2001: Tineke J Smilde; Sanne van Wissen; Hub Wollersheim; Mieke D Trip; John J P Kastelein; Anton F H Stalenhoef
Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.
Lancet 2001;357(9256):577-81.
2001: Anton F H Stalenhoef; Magda P C Hectors; P N Demacker
Effect of plant sterol-enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia.
Journal of internal medicine 2001;249(2):163-6.
2001: Frouwkje de Waart; Evert G Schouten; Anton F H Stalenhoef; Frans J Kok
Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly.
International journal of epidemiology 2001;30(1):136-43.
2001: Baukje de Roos; Muriel J Caslake; Anton F H Stalenhoef; Dorothy Bedford; P N Demacker; Martijn B Katan; Chris J Packard
The coffee diterpene cafestol increases plasma triacylglycerol by increasing the production rate of large VLDL apolipoprotein B in healthy normolipidemic subjects.
The American journal of clinical nutrition 2001;73(1):45-52.
2000: Pierre N M Demacker; Mario J Veerkamp; S J H Bredie; S M Marcovina; Jacqueline de Graaf; Anton F H Stalenhoef
Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia.
Atherosclerosis 2000;153(2):483-90.
2000: F W P J van den Berkmortel; Pierre N M Demacker; Hub Wollersheim; Theo Thien; Anton F H Stalenhoef
Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation.
European journal of clinical investigation 2000;30(11):972-9.
2000: Lambertus J H Van Tits; Heidi L M Hak-Lemmers; Pierre N M Demacker; Anton F H Stalenhoef; P H Willems
Oxidized low-density lipoprotein induces calcium influx in polymorphonuclear leukocytes.
Free radical biology & medicine 2000;29(8):747-55.
2000: A A Kroon; M A van't Hof; Pierre N M Demacker; Anton F H Stalenhoef
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
Atherosclerosis 2000;152(2):519-26.
2000: Natasja De Bont; Mihai G Netea; Pierre N M Demacker; Bart Jan Kullberg; Jos W M van der Meer; Anton F H Stalenhoef
Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae.
European journal of clinical investigation 2000;30(9):818-22.
2000: M J Hoffer; Harold Snieder; S J H Bredie; Pierre N M Demacker; John J P Kastelein; Rune R Frants; Anton F H Stalenhoef
The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
Atherosclerosis 2000;151(2):443-50.
2000: Jacqueline de Graaf; M J Hoffer; P M J Stuyt; Rune R Frants; Anton F H Stalenhoef
Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIV(Nijmegen).
Biochemical and biophysical research communications 2000;273(3):1084-7.
2000: Frouwkje de Waart; Tineke J Smilde; Hub Wollersheim; Anton F H Stalenhoef; Frans J Kok
Smoking characteristics, antioxidant vitamins, and carotid artery wall thickness among life-long smokers.
Journal of clinical epidemiology 2000;53(7):707-14.
2000: Tineke J Smilde; F W P J van den Berkmortel; Hub Wollersheim; Herman van Langen; J J Kastelein; Anton F H Stalenhoef
The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia.
European journal of clinical investigation 2000;30(6):473-80.
2000: Jacqueline de Graaf; Anton F H Stalenhoef
[Use of margarine fortified with phytosterols as a therapeutic food].
Nederlands tijdschrift voor geneeskunde 2000;144(20):918-21.
2000: Pierre N M Demacker; Magda P C Hectors; Anton F H Stalenhoef
Chylomicron processing in familial dysbetalipoproteinemia and familial combined hyperlipidemia studied with vitamin A and E as markers: a new physiological concept.
Atherosclerosis 2000;149(1):169-80.
2000: Anton F H Stalenhoef
['Cholesterol' guidelines (first revision) of the Dutch College of Family Physicians; response from internal medicine].
Nederlands tijdschrift voor geneeskunde 2000;144(9):407-9.
2000: Mihai G Netea; C H Selzman; Bart Jan Kullberg; J M Galama; A Weinberg; Anton F H Stalenhoef; Jos W M van der Meer; C A Dinarello
Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.
European journal of immunology 2000;30(2):541-9.
2000: Lambertus J H Van Tits; Pierre N M Demacker; Jacqueline de Graaf; Heidi L M Hak-Lemmers; Anton F H Stalenhoef
alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals.
The American journal of clinical nutrition 2000;71(2):458-64.
2000: Tineke J Smilde; Mieke D Trip; Sanne van Wissen; Hub Wollersheim; John J P Kastelein; Anton F H Stalenhoef
Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.
Clinical drug investigation 2000;20(2):67-79.
1999: Anton F H Stalenhoef
Management of serum lipid levels into the next millennium: new targets for treatment.
The Netherlands journal of medicine 1999;55(6):300-3.
1999: A A Kroon; Pierre N M Demacker; H A Kleinveld; Anton F H Stalenhoef
The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability.
Atherosclerosis 1999;147(1):105-13.
1999: Natasja De Bont; T B Geijtenbeek; Mihai G Netea; Tineke J Smilde; Pierre N M Demacker; Carl Figdor; Jos W M van der Meer; Anton F H Stalenhoef
Integrin mediated adhesion of mononuclear cells from patients with familial hypercholesterolemia.
European journal of clinical investigation 1999;29(9):749-57.
1999: Romana T Netea; Mihai G Netea; S J H Bredie; Pierre N M Demacker; N Hancu; Theo Thien; Anton F H Stalenhoef
Lipoprotein (a) concentrations in patients with familial combined hyperlipidemia and hypertension.
The Netherlands journal of medicine 1999;55(1):39-45.
1999: Natasja De Bont; Mihai G Netea; Pierre N M Demacker; Ineke Verschueren; Bart Jan Kullberg; Ko Willems van Dijk; Jos W M van der Meer; Anton F H Stalenhoef
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection.
Journal of lipid research 1999;40(4):680-5.
1998: Pierre N M Demacker; S J H Bredie; Magda P C Hectors; Anton F H Stalenhoef
Fat loading experiments with the vitamins A and E suggest that in postprandial lipemia transfer/diffusion of chylomicron lipids to VLDL contributes to beta-VLDL formation.
Atherosclerosis 1998;141 Suppl 1():S109-13.
1998: Tineke J Smilde; F W P J van den Berkmortel; Godfried H J Boers; Hub Wollersheim; Theo M de Boo; Herman van Langen; Anton F H Stalenhoef
Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(12):1958-63.
1998: Chantal Rovers; Mihai G Netea; Natasja De Bont; Pierre N M Demacker; C Jacobs; Bart Jan Kullberg; Jos W M van der Meer; Anton F H Stalenhoef
LPS-induced cytokine production and expression of beta2-integrins and CD14 by peripheral blood mononuclear cells of patients with homozygous familial hypercholesterolemia.
Atherosclerosis 1998;141(1):99-105.
1998: P M J Stuyt; H A Kleinjans; Anton F H Stalenhoef
Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia.
The Netherlands journal of medicine 1998;53(5):228-33.
1998: Mihai G Netea; Pierre N M Demacker; Bart Jan Kullberg; Otto Boerman; Ineke Verschueren; Anton F H Stalenhoef; Jos W M van der Meer
Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.
Immunology 1998;95(3):466-72.
1998: Mihai G Netea; Pierre N M Demacker; Bart Jan Kullberg; Liesbeth E H Jacobs; Trees J G Verver-Jansen; Otto Boerman; Anton F H Stalenhoef; Jos W M van der Meer
Bacterial lipopolysaccharide binds and stimulates cytokine-producing cells before neutralization by endogenous lipoproteins can occur.
Cytokine 1998;10(10):766-72.
1998: Natasja De Bont; Mihai G Netea; Chantal Rovers; Tineke J Smilde; Pierre N M Demacker; Jos W M van der Meer; Anton F H Stalenhoef
LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors.
Atherosclerosis 1998;139(1):147-52.
1998: Pierre N M Demacker; S J H Bredie; J M Vogelaar; Magda P C Hectors; P van Heijst; P M J Stuyt; Anton F H Stalenhoef
Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins.
Atherosclerosis 1998;138(2):301-12.
1998: Jacqueline de Graaf; Anton F H Stalenhoef
Defects of lipoprotein metabolism in familial combined hyperlipidaemia.
Current opinion in lipidology 1998;9(3):189-96.
1998: M J Hoffer; S J H Bredie; Harold Snieder; P W Reymer; Pierre N M Demacker; Louis M Havekes; dorret boomsma; Anton F H Stalenhoef; Rune R Frants; John J P Kastelein
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemia.
Atherosclerosis 1998;138(1):91-9.
1998: T Diekman; P N Demacker; John J P Kastelein; Anton F H Stalenhoef; Wilmar M Wiersinga
Increased oxidizability of low-density lipoproteins in hypothyroidism.
The Journal of clinical endocrinology and metabolism 1998;83(5):1752-5.
1998: Mihai G Netea; Natasja De Bont; Pierre N M Demacker; Bart Jan Kullberg; Liesbeth E H Jacobs; Trees J G Verver-Jansen; Anton F H Stalenhoef; Jos W M van der Meer
Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.
Infection and immunity 1998;66(5):2365-7.
1997: Tineke J Smilde; Hub Wollersheim; Herman van Langen; Anton F H Stalenhoef
Reproducibility of ultrasonographic measurements of different carotid and femoral artery segments in healthy subjects and in patients with increased intima-media thickness.
Clinical science (London, England : 1979) 1997;93(4):317-24.
1997: S J H Bredie; Pierre N M Demacker; Anton F H Stalenhoef
Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity.
European journal of clinical investigation 1997;27(10):802-11.
1997: Anton F H Stalenhoef; A A Kroon; Wim R M Aengevaeren
Aggressive lipid lowering treatment in coronary atherosclerosis.
Cardiologia (Rome, Italy) 1997;42(9):935-40.
1997: S J H Bredie; C J Tack; P Smits; Anton F H Stalenhoef
Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(7):1465-71.
1997: A A Kroon; Anton F H Stalenhoef
LDL-cholesterol lowering and atherosclerosis--clinical benefit and possible mechanisms: an update.
The Netherlands journal of medicine 1997;51(1):16-27.
1997: Anton F H Stalenhoef; P M J Stuyt; Jacqueline de Graaf
Effects of ketoconazole on plasma lipids and lipoprotein(a) in familial hypercholesterolaemia, compared with simvastatin.
The Netherlands journal of medicine 1997;51(1):10-5.
1997: Mihai G Netea; Pierre N M Demacker; Natasja De Bont; Otto Boerman; Anton F H Stalenhoef; Jos W M van der Meer; Bart Jan Kullberg
Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.
Infection and immunity 1997;65(7):2663-7.
1997: S J H Bredie; J van Drongelen; L A Kiemeney; Pierre N M Demacker; Terri H beaty; Anton F H Stalenhoef
Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(5):834-40.
1997: M J Mol; YB de Rijke; Pierre N M Demacker; Anton F H Stalenhoef
Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment.
Atherosclerosis 1997;129(2):169-76.
1997: YB de Rijke; S J H Bredie; Pierre N M Demacker; J M Vogelaar; Heidi L M Hak-Lemmers; Anton F H Stalenhoef
The redox status of coenzyme Q10 in total LDL as an indicator of in vivo oxidative modification. Studies on subjects with familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(1):127-33.
1996: Wim R M Aengevaeren; A A Kroon; Anton F H Stalenhoef; Gérard J H Uijen; T van der Werf
Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
Journal of the American College of Cardiology 1996;28(7):1696-704.
1996: S J H Bredie; J M Vogelaar; Pierre N M Demacker; Anton F H Stalenhoef
Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Atherosclerosis 1996;126(2):313-24.
1996: S J H Bredie; H Tineke Westerveld; H C Knipscheer; Tjerk W A de Bruin; J J Kastelein; Anton F H Stalenhoef
Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
The Netherlands journal of medicine 1996;49(2):59-67.
1996: A A Kroon; Wim R M Aengevaeren; T van der Werf; Gérard J H Uijen; J H Reiber; A V G Bruschke; Anton F H Stalenhoef
LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis.
Circulation 1996;93(10):1826-35.
1996: S J H Bredie; L A Kiemeney; A F de Haan; Pierre N M Demacker; Anton F H Stalenhoef
Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
American journal of human genetics 1996;58(4):812-22.
1996: Mihai G Netea; Pierre N M Demacker; Bart Jan Kullberg; Otto Boerman; Ineke Verschueren; Anton F H Stalenhoef; Jos W M van der Meer
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.
The Journal of clinical investigation 1996;97(6):1366-72.
1995: A A Kroon; N Ajubi; W N van Asten; Anton F H Stalenhoef
The prevalence of peripheral vascular disease in familial hypercholesterolaemia.
Journal of internal medicine 1995;238(5):451-9.
1995: Luuk B Hilbrands; Pierre N M Demacker; Andries J Hoitsma; Anton F H Stalenhoef; R A P Koene
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Journal of the American Society of Nephrology : JASN 1995;5(12):2073-81.
1995: R E Knops; A A Kroon; M J Mol; P M J Stuyt; Anton F H Stalenhoef
Long-term experience (6 years) with simvastatin in patients with heterozygous familial hypercholesterolaemia.
The Netherlands journal of medicine 1995;46(4):171-8.
1995: Anton F H Stalenhoef; V W Armstrong; A Steinmetz; M R Taskinen; R Zechner
The 17th annual meeting of the European Lipoprotein Club.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(4):543-9.
1995: S J H Bredie; Tjerk W A de Bruin; Pierre N M Demacker; J J Kastelein; Anton F H Stalenhoef
Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
The American journal of cardiology 1995;75(5):348-53.
1995: H A Kleinveld; H L Hak-Lemmers; M P Hectors; N J de Fouw; Pierre N M Demacker; Anton F H Stalenhoef
Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(2):290-7.
1994: A A Kroon; Dorine W Swinkels; P W van Dongen; Anton F H Stalenhoef
Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis.
Metabolism: clinical and experimental 1994;43(9):1164-70.
1994: H A Kleinveld; Pierre N M Demacker; Anton F H Stalenhoef
Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(8):1386-91.
1994: Anton F H Stalenhoef; J C Defesche; H A Kleinveld; Pierre N M Demacker; J J Kastelein
Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):489-93.
1993: J de Graaf; Pierre N M Demacker; Anton F H Stalenhoef
The effect of simvastatin treatment on the low-density lipoprotein subfraction profile and composition in familial hypercholesterolaemia.
The Netherlands journal of medicine 1993;43(5-6):254-61.
1993: A A Kroon; Anton F H Stalenhoef; H Buikema; Pierre N M Demacker; P C de Wilde; P A Leijten; W H van Gilst
The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
Atherosclerosis 1993;103(2):221-30.
1993: H A Kleinveld; A H Naber; Anton F H Stalenhoef; Pierre N M Demacker
Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects.
Free radical biology & medicine 1993;15(3):273-80.
1993: Pierre N M Demacker; A G Hijmans; H A Kleinveld; Anton F H Stalenhoef
Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidants.
Atherosclerosis 1993;102(1):69-77.
1993: M J Mol; Pierre N M Demacker; Anton F H Stalenhoef
The role of modification of lipoproteins and of the immune system in early atherogenesis.
The Netherlands journal of medicine 1993;43(1-2):83-90.
1993: Anton F H Stalenhoef; P J Lansberg; A A Kroon; B Kortmann; A F De Haan; P M J Stuyt; J J Kastelein
Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
Journal of internal medicine 1993;234(1):77-82.
1993: J de Graaf; J C Hendriks; Pierre N M Demacker; Anton F H Stalenhoef
Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(5):712-9.
1993: H A Kleinveld; Pierre N M Demacker; A F De Haan; Anton F H Stalenhoef
Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors.
European journal of clinical investigation 1993;23(5):289-95.
1993: J de Graaf; Dorine W Swinkels; Pierre N M Demacker; A F de Haan; Anton F H Stalenhoef
Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.
The Journal of clinical endocrinology and metabolism 1993;76(1):197-202.
1993: J de Graaf; J C Hendriks; Dorine W Swinkels; Pierre N M Demacker; Anton F H Stalenhoef
Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
Artery 1993;20(4):201-30.
1992: A A Kroon; M J Mol; Anton F H Stalenhoef
ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.
Lancet 1992;340(8833):1476.
1992: J de Graaf; Dorine W Swinkels; A F de Haan; Pierre N M Demacker; Anton F H Stalenhoef
Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.
American journal of human genetics 1992;51(6):1295-310.
1992: H A Kleinveld; H L Hak-Lemmers; Anton F H Stalenhoef; Pierre N M Demacker
Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein.
Clinical chemistry 1992;38(10):2066-72.
1992: Pierre N M Demacker; P J van Heijst; Anton F H Stalenhoef
A study of the chylomicron metabolism in WHHL rabbits after fat loading. Discrepancy between results based on measurement of apoprotein B-48 or retinyl palmitate.
The Biochemical journal 1992;285 ( Pt 2)():641-6.
1992: H A Kleinveld; Pierre N M Demacker; Anton F H Stalenhoef
Failure of N-acetylcysteine to reduce low-density lipoprotein oxidizability in healthy subjects.
European journal of clinical pharmacology 1992;43(6):639-42.
1991: A A Kroon; Pierre N M Demacker; Anton F H Stalenhoef
N-acetylcysteine and serum concentrations of lipoprotein(a).
Journal of internal medicine 1991;230(6):519-26.
1991: Pierre N M Demacker; B Staels; Anton F H Stalenhoef; J Auwerx
Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase, and the low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(6):1652-9.
1991: M J Mol; Anton F H Stalenhoef; Pierre N M Demacker; A van 't Laar
Alterations in the metabolism of very-low- and low-density lipoproteins after partial ileal-bypass surgery in the Watanabe heritable hyperlipidaemic rabbit.
The Biochemical journal 1991;278 ( Pt 3)():651-7.
1991: P M J Stuyt; B J Brenninkmeijer; Pierre N M Demacker; J C Hendriks; P van Elteren; Anton F H Stalenhoef; A van 't Laar
Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
Scandinavian journal of clinical and laboratory investigation 1991;51(5):425-35.
1991: P M J Stuyt; M J Mol; Anton F H Stalenhoef
Long-term effects of simvastatin in familial dysbetalipoproteinaemia.
Journal of internal medicine 1991;230(2):151-5.
1991: T P Dormans; Dorine W Swinkels; J de Graaf; J C Hendriks; Anton F H Stalenhoef; Pierre N M Demacker
Single-spin density-gradient ultracentrifugation vs gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared.
Clinical chemistry 1991;37(6):853-8.
1991: M van Dusseldorp; M B Katan; T van Vliet; Pierre N M Demacker; Anton F H Stalenhoef
Cholesterol-raising factor from boiled coffee does not pass a paper filter.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(3):586-93.
1991: Pierre N M Demacker; I G Reijnen; M B Katan; P M J Stuyt; Anton F H Stalenhoef
Increased removal of remnants of triglyceride-rich lipoproteins on a diet rich in polyunsaturated fatty acids.
European journal of clinical investigation 1991;21(2):197-203.
1991: J de Graaf; H L Hak-Lemmers; M P Hectors; Pierre N M Demacker; J C Hendriks; Anton F H Stalenhoef
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1991;11(2):298-306.
1990: Pierre N M Demacker; M J Mol; Anton F H Stalenhoef
Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol.
The Biochemical journal 1990;272(3):647-51.
1990: Dorine W Swinkels; J C Hendriks; Pierre N M Demacker; Anton F H Stalenhoef
Differences in metabolism of three low density lipoprotein subfractions in Hep G2 cells.
Biochimica et biophysica acta 1990;1047(3):212-22.
1990: Peter de Knijff; Anton F H Stalenhoef; M J Mol; J A Gevers Leuven; J Smit; D Willem Erkelens; J Schouten; Rune R Frants; Louis M Havekes
Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
Atherosclerosis 1990;83(1):89-97.
1990: M J Mol; Anton F H Stalenhoef
Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
The Netherlands journal of medicine 1990;36(5-6):279-87.
1990: M J Mol; P M J Stuyt; Pierre N M Demacker; Anton F H Stalenhoef
The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
The Netherlands journal of medicine 1990;36(3-4):182-90.
1990: P M J Stuyt; M J Mol; Anton F H Stalenhoef; Pierre N M Demacker; A Van 't Laar
Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
The American journal of medicine 1990;88(1N):42N-45N.
1989: M J Mol; Anton F H Stalenhoef; P M J Stuyt; Ad R M M Hermus; Pierre N M Demacker; A Van 'T Laar
Effects of inhibition of cholesterol synthesis by simvastatin on the production of adrenocortical steroid hormones and ACTH.
Clinical endocrinology 1989;31(6):679-89.
1989: Anton F H Stalenhoef; M J Mol; P M J Stuyt
Efficacy and tolerability of simvastatin (MK-733).
The American journal of medicine 1989;87(4A):39S-43S.
1989: M J Mol; Anton F H Stalenhoef; Pierre N M Demacker; A van't Laar
Low-density lipoprotein catabolism in WHHL rabbits after partial ileal bypass surgery.
Biochimica et biophysica acta 1989;1003(2):167-74.
1989: M J Mol; P M J Stuyt; Anton F H Stalenhoef
[Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Nederlands tijdschrift voor geneeskunde 1989;133(7):362-6.
1988: H J Smeets; J Poddighe; P M J Stuyt; Anton F H Stalenhoef; H H Ropers; B Wieringa
Identification of apolipoprotein E polymorphism by using synthetic oligonucleotides.
Journal of lipid research 1988;29(9):1231-7.
1988: M J Mol; P M J Stuyt; Anton F H Stalenhoef; A van 't Laar
Cholesterol synthesis inhibitors in hyperlipidaemia.
Lancet 1988;1(8585):597.
1988: M J Mol; D Willem Erkelens; J A Gevers Leuven; J A Schouten; Anton F H Stalenhoef
Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
Atherosclerosis 1988;69(2-3):131-7.
1988: Pierre N M Demacker; A G Hijmans; Anton F H Stalenhoef; A van 't Laar
Studies on the function of hepatic lipase in the cat after immunological blockade of the enzyme in vivo.
Atherosclerosis 1988;69(2-3):173-83.
1987: B J Brenninkmeijer; P M J Stuyt; Pierre N M Demacker; Anton F H Stalenhoef; A van 't Laar
Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.
Journal of lipid research 1987;28(4):361-70.
1986: M J Mol; D Willem Erkelens; J A Leuven; J A Schouten; Anton F H Stalenhoef
Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
Lancet 1986;2(8513):936-9.
1985: P M J Stuyt; Anton F H Stalenhoef; Pierre N M Demacker; A Van 't Laar
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Atherosclerosis 1985;55(1):51-62.
1983: Pierre N M Demacker; D F van Sommeren-Zondag; Anton F H Stalenhoef; P M J Stuyt; A van't Laar
Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3.
Clinical chemistry 1983;29(4):656-63.
1982: P M J Stuyt; Anton F H Stalenhoef; Pierre N M Demacker; A van't Laar
Hyperlipoproteinemia type V and apolipoprotein E4.
Lancet 1982;2(8304):934.
1982: Anton F H Stalenhoef; Pierre N M Demacker; J A Lutterman; A van't Laar
Apolipoprotein C in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.
Diabetologia 1982;22(6):489-91.
1982: Pierre N M Demacker; R W Schade; Anton F H Stalenhoef; P M J Stuyt; A van't Laar
Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.
British medical journal (Clinical research ed.) 1982;284(6324):1213-5.
1982: P M J Stuyt; Pierre N M Demacker; Anton F H Stalenhoef; R W Schade; J A Lutterman; A van't Laar
Type III hyperlipoproteinaemia: the turnover rate of plasma triglycerides and the response to clofibrate.
The Netherlands journal of medicine 1982;25(8):245-54.
1981: Anton F H Stalenhoef; Pierre N M Demacker; J A Lutterman; A Van't Laar
Severe hypertriglyceridaemia associated with altered apolipoprotein C and E composition of the triglyceride-rich lipoproteins.
The Netherlands journal of medicine 1981;24(4):145-51.